• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PAPNET系统在常规病理学服务中的评估。

Evaluation of the PAPNET system in a general pathology service.

作者信息

Farnsworth A, Chambers F M, Goldschmidt C S

出版信息

Med J Aust. 1996 Oct 21;165(8):429-31.

PMID:8913244
Abstract

OBJECTIVE

To compare the results of an automated rescreening device (PAPNET) with manual screening of Papanicolaou (Pap) smears.

DESIGN

All normal or technically unsatisfactory smears and a random sample of abnormal smears on manual screening were submitted for PAPNET rescreening.

SETTING

Large general pathology laboratory in Sydney between January and September 1995.

RESULTS

Of 54,658 PAP smears classified on manual screening as normal 266 were reclassified as abnormal after PAPNET screening (32 atypical squamous cells of uncertain significance, 217 low-grade squamous intraepithelial lesions and 17 high-grade intraepithelial lesions). Of the random sample of 1022 smears classified on manual screening as abnormal, all high-grade intraepithelial lesions (122 smears) and squamous cell carcinomas (2 smears) were also detected by PAPNET, and 112 were reclassified as normal by PAPNET (14 atypical squamous cells of uncertain significance and 98 low-grade squamous intraepithelial lesions). Histological follow-up confirmed 15 of the 17 smears classified as high-grade intraepithelial lesions on PAPNET screening and detected a further seven that had been classified by PAPNET as either atypical squamous cells of uncertain significance or low-grade squamous intraepithelial lesions.

CONCLUSIONS

When used as a quality-control measure in a general pathology laboratory, the PAPNET automated screening system detects higher numbers of abnormal PAP smears than manual screening.

摘要

目的

比较自动复查设备(PAPNET)与巴氏涂片手动筛查的结果。

设计

所有手动筛查为正常或技术上不合格的涂片以及手动筛查为异常涂片的随机样本均提交给PAPNET进行复查。

地点

1995年1月至9月悉尼的大型普通病理实验室。

结果

在手动筛查分类为正常的54658份巴氏涂片中,PAPNET筛查后有266份被重新分类为异常(32例意义不明确的非典型鳞状细胞、217例低级别鳞状上皮内病变和17例高级别上皮内病变)。在手动筛查分类为异常的1022份涂片随机样本中,PAPNET也检测出了所有高级别上皮内病变(122份涂片)和鳞状细胞癌(2份涂片),并且有112份被PAPNET重新分类为正常(14例意义不明确的非典型鳞状细胞和98例低级别鳞状上皮内病变)。组织学随访证实了PAPNET筛查中分类为高级别上皮内病变的17份涂片中的15份,并检测出另外7份被PAPNET分类为意义不明确的非典型鳞状细胞或低级别鳞状上皮内病变的涂片。

结论

在普通病理实验室用作质量控制措施时,PAPNET自动筛查系统比手动筛查能检测出更多异常巴氏涂片。

相似文献

1
Evaluation of the PAPNET system in a general pathology service.PAPNET系统在常规病理学服务中的评估。
Med J Aust. 1996 Oct 21;165(8):429-31.
2
PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma.在高级别鳞状上皮内病变或癌诊断之前,对报告为阴性的涂片进行PAPNET分析。
Mod Pathol. 1994 Jun;7(5):578-81.
3
PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy.PAPNET辅助的宫颈涂片复查:与100%人工复查策略相比的成本和准确性
JAMA. 1998 Jan 21;279(3):235-7. doi: 10.1001/jama.279.3.235.
4
Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation. A community hospital's experience.用于宫颈细胞学评估的PAPNET二次筛查技术的成本与结果。一家社区医院的经验。
Arch Fam Med. 1999 Jan-Feb;8(1):52-5. doi: 10.1001/archfami.8.1.52.
5
PAPNET-directed rescreening of cervicovaginal smears: a study of 101 cases of atypical squamous cells of undetermined significance.基于计算机辅助细胞检测系统(PAPNET)指导下的宫颈阴道涂片复查:101例意义不明确的非典型鳞状细胞病例研究
Am J Clin Pathol. 1996 Jun;105(6):711-8. doi: 10.1093/ajcp/105.6.711.
6
Rescreening of atypical cervicovaginal smears using PAPNET.使用PAPNET对非典型宫颈阴道涂片进行重新筛查。
Cancer. 1998 Dec 25;84(6):361-5.
7
Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.用于宫颈涂片质量控制的PAPNET细胞学筛查系统评估
Am J Clin Pathol. 1994 Feb;101(2):220-9. doi: 10.1093/ajcp/101.2.220.
8
PAPNET testing for HSILs. The few cell/small cell challenge.用于高级别鳞状上皮内病变(HSILs)的PAPNET检测。少量细胞/小细胞难题。
Acta Cytol. 1998 Jan-Feb;42(1):253-9. doi: 10.1159/000331554.
9
Rescreen effect in conventional and PAPNET screening: observed in a study using material enriched with positive smears.传统筛查和PAPNET筛查中的复查效应:在一项使用富含阳性涂片样本的研究中观察到。
Acta Cytol. 1998 Sep-Oct;42(5):1133-8. doi: 10.1159/000332101.
10
Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System.CIN 3/癌之前的宫颈涂片阴性。采用PAPNET检测系统进行重新评估。
Acta Cytol. 1997 Jan-Feb;41(1):74-8. doi: 10.1159/000332308.

引用本文的文献

1
BestCyte® primary screening of 500 ThinPrep Pap Test thin-layers: 3 Cytologists' Interobserver diagnostic concordance with predicate manual microscopy relative to Truth Reference diagnoses defining NILM, ASCUS+, LSIL+, and ASCH+ thresholds for specificity, sensitivity, and equivalency grading.500例液基薄层巴氏涂片的BestCyte®初步筛查:3位细胞病理学家之间的观察者间诊断一致性,与相对于真实参考诊断的谓词手工显微镜检查结果相比,确定了无上皮内病变或恶性病变(NILM)、意义不明确的非典型鳞状细胞(ASCUS+)、低度鳞状上皮内病变(LSIL+)和非典型鳞状细胞不能排除高级别鳞状上皮内病变(ASCH+)阈值的特异性、敏感性和等效性分级。
J Pathol Inform. 2023 Jan 2;14:100182. doi: 10.1016/j.jpi.2022.100182. eCollection 2023.